Maternal Flt-1 and endoglin expression by circulating monocyte subtype and polarization in preeclampsia and fetal growth restriction

Maternal Flt-1 and endoglin expression by circulating monocyte subtype and polarization in preeclampsia and fetal growth restriction

Objective: Circulating levels of the anti-angiogenic factors sFlt-1 and sEndoglin are elevated in preeclampsia (PE) and fetal growth restriction (FGR), mainly secreted from placental trophoblast. This study aims to identify the contributory role of monocyte Flt-1 and endoglin expression in PE and FG...

Full description

Bibliographic Details
Main Authors:	Thushari Indika Alahakoon, Heather Medbury, Helen Williams, Nicole Fewings, Xin Wang, Vincent Lee
Format:	Article
Language:	English
Published:	Elsevier 2019-07-01
Series:	European Journal of Obstetrics & Gynecology and Reproductive Biology: X
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590161319300596

Similar Items

Lipid profiling in maternal and fetal circulations in preeclampsia and fetal growth restriction-a prospective case control observational study
by: Thushari I. Alahakoon, et al.
Published: (2020-01-01)

Investigation of the presence of Flt-1 and endoglin on syncytiotrophoblast microparticles
by: Tannetta, D, et al.
Published: (2008)

MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin.
by: Tu'uhevaha J Kaitu'u-Lino, et al.
Published: (2012-01-01)

Circulating soluble endoglin levels in pregnant women in Cameroon and Malawi--associations with placental malaria and fetal growth restriction.
by: Karlee L Silver, et al.
Published: (2011-01-01)

Correction: Circulating Soluble Endoglin Levels in Pregnant Women in Cameroon and Malawi—Associations with Placental Malaria and Fetal Growth Restriction
Published: (2011-01-01)

Correction: Circulating Soluble Endoglin Levels in Pregnant Women in Cameroon and Malawi—Associations with Placental Malaria and Fetal Growth Restriction.
by: Karlee L. Silver, et al.
Published: (2011-01-01)

Soluble endoglin versus sFlt-1/PlGF ratio: detection of preeclampsia, HELLP syndrome, and FGR in a high-risk cohort
by: A. Iannaccone, et al.
Published: (2022-10-01)

Smoking and Fetal Growth Restriction in Preeclampsia
by: Hayes, J, et al.
Published: (2008)

Circulating Platelet- and Placenta-Derived Microparticles Expose Flt-1 in Preeclampsia
by: Lok, C, et al.
Published: (2008)

Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia.
by: Reddy, A, et al.
Published: (2009)

Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia
by: Reddy, A, et al.
Published: (2009)

Maternal circulating levels of activin A, inhibin A, dFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia
by: Reddy, A, et al.
Published: (2009)

Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia.
by: Aparna Reddy, et al.
Published: (2009-01-01)

Differences in levelFms-Like Tyrosine Kinase-1 (sFlt-1), soluble Endoglin (s-Eng), and Placental Growth Factor (PIGF) between Early Onset Preeclampsia and Late Onset Preeclampsia
by: Lita Nafratilova, et al.
Published: (2018-10-01)

Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin
by: Tannetta, D, et al.
Published: (2013)

Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin.
by: Dionne S Tannetta, et al.
Published: (2013-01-01)

Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
by: Natalie J. Hannan, et al.
Published: (2017-05-01)

Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.
by: Robert W Powers, et al.
Published: (2010-10-01)

Circulating platelet-derived and placenta-derived microparticles expose Flt-1 in preeclampsia.
by: Lok, C, et al.
Published: (2008)

Diagnostic and prognostic significance of serum soluble endoglin levels in preeclampsia and eclampsia
by: Rekha Sachan, et al.
Published: (2016-01-01)

Clinical Differences of Fetal Growth Restriction with or without Preeclampsia
by: Hayes, J, et al.
Published: (2008)

Role of angiopoietin-2, endoglin, and placental growth factor in HIV-associated preeclampsia
by: Nokuzola Mbhele, et al.
Published: (2017-07-01)

Relationship of Liver X Receptors α and Endoglin Levels in Serum and Placenta with Preeclampsia.
by: Jing Wang, et al.
Published: (2016-01-01)

Soluble Endoglin Serum Level is Higher in Preeclampsia Compared to Molar and Normal Pregnancy
by: Maya K. Puspitasari, et al.
Published: (2014-04-01)

Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia.
by: Sarosh Rana, et al.
Published: (2012-01-01)

Editorial: Role of membrane-bound and circulating endoglin in disease
by: Carmelo Bernabeu, et al.
Published: (2023-09-01)

Circulating endoglin concentration is not elevated in chronic kidney disease.
by: David M Charytan, et al.
Published: (2011-01-01)

Circulating soluble endoglin modifies the inflammatory response in mice.
by: Laura Ruiz-Remolina, et al.
Published: (2017-01-01)

Uterine Artery Doppler in Screening for Preeclampsia and Fetal Growth Restriction
by: Marianna Amaral Pedroso, et al.
Published: (2018-05-01)

Prediction of preeclampsia based on maternal serum endoglin level in women with pregestational diabetes mellitus
by: Roman V. Kapustin, et al.
Published: (2022-10-01)

Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia
by: Valeria Sandrim, et al.
Published: (2019-04-01)

Monocyte Differentiation and Heterogeneity: Inter-Subset and Interindividual Differences
by: Helen Williams, et al.
Published: (2023-05-01)

Nature versus Number: Monocytes in Cardiovascular Disease
by: Helen Williams, et al.
Published: (2021-08-01)

Paired maternal and fetal metabolomics reveal a differential fingerprint in preeclampsia versus fetal growth restriction
by: Lina Youssef, et al.
Published: (2021-07-01)

Proteomic Analysis of Maternal Urine for the Early Detection of Preeclampsia and Fetal Growth Restriction
by: Emmanuel Bujold, et al.
Published: (2021-10-01)

Pregnancy-Induced High Plasma Levels of Soluble Endoglin in Mice Lead to Preeclampsia Symptoms and Placental Abnormalities
by: Lucía Pérez-Roque, et al.
Published: (2020-12-01)

Maternal Serum Concentrations of Corin, Endoglin, PP13, and sFlt-1 and their Changes with Advancement of Pregnancy and Correlation with Doppler of Uterine Arteries
by: Chalova Krasimira I., et al.
Published: (2018-12-01)

The sFlt1/PlGF ratio predicts faster fetal deterioration in early fetal growth restriction: a historical cohort study
by: Palma Dos Reis, CR, et al.
Published: (2023)

Monocyte Subset Recruitment Marker Profile Is Inversely Associated With Blood ApoA1 Levels
by: Vyoma K. Patel, et al.
Published: (2021-02-01)

Endoglin: Beyond the Endothelium
by: Mark J.A. Schoonderwoerd, et al.
Published: (2020-02-01)